Investor FAQs

Medpace was founded in 1992.

5375 Medpace Way
Cincinnati, Ohio 45227
513-579-9911

The common stock of Medpace began trading on August 11, 2016. The initial public offering consisted of 8,050,000 shares.

The common stock of Medpace is traded under the symbol “MEDP” on the Nasdaq Global Select Market.

Medpace’s CUSIP number is 58506Q109.

Please refer to the “About Medpace” section contained in our most recent press release for the most current number of worldwide employees.

Medpace’s fiscal year ends December 31.

Deloitte & Touche LLP

Keating Muething & Klekamp PLL

You may purchase shares of Medpace’s stock through a registered broker.
The Company does not have a direct purchase program available to the public.

Beneficial stockholders with shares held by a broker in the name of the brokerage house should contact their broker on all administrative matters. If you are a registered stockholder and have questions regarding your account status, please contact Medpace’s transfer agent.

Equiniti Trust Company, LLC
718-921-8124

The Company does not currently pay a dividend. Any decision to declare and pay a dividend in the future will be made at the sole discretion of Medpace’s Board of Directors and will depend on, among other things, Medpace’s financial condition and results of operations, restrictions in its debt instruments, capital requirements, contractual and legal restrictions, and other factors that its Board of Directors may deem relevant.

Medpace will file periodic reports, including Annual Reports (Form 10-K), Quarterly Reports (Form 10-Q), and Current Reports (Form 8-K) with the Securities and Exchange Commission (SEC). These reports are available on the SEC Filings page. In addition, Medpace will post recent financial information in the form on quarterly earnings releases, webcasts, and presentations on the “Investors” page of the Company’s website at www.medpace.com.

Click here to be added to Medpace’s distribution list.

Investor questions and inquiries should be directed to investor@medpace.com.

Please submit your question using this form.